Vaksin Covid-19 Oxford–AstraZeneca (Indonesian Wikipedia)

Analysis of information sources in references of the Wikipedia article "Vaksin Covid-19 Oxford–AstraZeneca" in Indonesian language version.

refsWebsite

Global rank Indonesian rank

9web.archive.org

1^st place

8doi.org

2^nd place

4^th place

6nih.gov

4^th place

13^th place

5europa.eu

68^th place

182^nd place

4worldcat.org

5^th place

7^th place

2covid19vaccinetrial.co.uk

low place

2who.int

195^th place

203^rd place

2bbc.com

20^th place

50^th place

2cnn.com

28^th place

70^th place

2ox.ac.uk

613^th place

703^rd place

1clinicaltrials.gov

5,225^th place

low place

1clinicaltrialsregister.eu

low place

1bbc.co.uk

8^th place

18^th place

1tandfonline.com

507^th place

524^th place

1canada.ca

1,712^th place

7,978^th place

1ourworldindata.org

2,263^rd place

3,281^st place

1reuters.com

49^th place

96^th place

1clinicaltrialsarena.com

low place

19news.com.au

4,754^th place

low place

1detik.com

586^th place

5^th place

1voaindonesia.com

low place

616^th place

1cnnindonesia.com

1,737^th place

20^th place

1nature.com

234^th place

238^th place

1gavi.org

low place

1usatoday.com

41^st place

187^th place

1gov.uk

432^nd place

1,425^th place

1bmj.com

1,226^th place

1,806^th place

1indiatimes.com

17^th place

101^st place

1pharmaceutical-technology.com

low place

1thelancet.com

2,393^rd place

5,647^th place

1ouh.nhs.uk

low place

1sky.com

431^st place

1,247^th place

1astrazeneca.com

low place

1verywellhealth.com

low place

3,967^th place

1nationalgeographic.com

344^th place

276^th place

1sciencefocus.com

low place

2,342^nd place

1telegraph.co.uk

30^th place

103^rd place

1ukri.org

low place

1practio.co.uk

low place

1msf.org

low place

1fiercepharma.com

low place

1apnews.com

129^th place

478^th place

1hindustantimes.com

71^st place

434^th place

1lstmed.ac.uk

low place

1sciencemag.org

857^th place

574^th place

1politico.eu

1,347^th place

3,142^nd place

1indianexpress.com

60^th place

408^th place

9news.com.au

"The Oxford University COVID-19 vaccine explained". www.9news.com.au. Diakses tanggal 2021-03-25.

apnews.com

"UK coronavirus vaccine prompts immune response in early test". AP NEWS. 2020-07-20. Diakses tanggal 2021-03-25.

astrazeneca.com

"COVID-19 Vaccine AstraZeneca confirms 100% protection against severe disease, hospitalisation and death in the primary analysis of Phase III trials". www.astrazeneca.com (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

bbc.co.uk

"Covid-19: Oxford-AstraZeneca coronavirus vaccine approved for use in UK". BBC News. BBC. 30 December 2020. Diakses tanggal 30 December 2020.

bbc.com

"Covid: What is the Oxford-AstraZeneca vaccine?". BBC News (dalam bahasa Inggris). 2021-03-22. Diakses tanggal 2021-03-25.
"Covid: What is the Oxford-AstraZeneca vaccine?". BBC News (dalam bahasa Inggris). 2021-03-22. Diakses tanggal 2021-03-25.

bmj.com

Wise, Jacqui (2021-02-03). "Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval". BMJ (dalam bahasa Inggris). 372: n326. doi:10.1136/bmj.n326. ISSN 1756-1833. PMID 33536232 Periksa nilai |pmid= (bantuan).

canada.ca

Public Health Agency of Canada, [Agence de la santé publique du Canada] (29 March 2021). "Use of AstraZeneca COVID-19 vaccine in younger adults" (Utilisation du vaccin AstraZeneca contre la COVID-19 chez les jeunes adultes). Government of Canada. Diakses tanggal 4 October 2021.

clinicaltrials.gov

"Investigating a Vaccine Against COVID-19". ClinicalTrials.gov (Registry). United States National Library of Medicine. 26 May 2020. NCT04400838. Diarsipkan dari versi asli tanggal 11 October 2020. Diakses tanggal 14 July 2020.

clinicaltrialsarena.com

"Oxford Covid-19 vaccine trials start in South Africa and Brazil". www.clinicaltrialsarena.com. Diakses tanggal 2021-03-25.

clinicaltrialsregister.eu

"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Diarsipkan dari versi asli tanggal 5 October 2020. Diakses tanggal 3 August 2020.

cnn.com

edition.cnn.com

Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William (27 July 2020). "The world's hopes for a coronavirus vaccine may run in these health care workers' veins". CNN. São Paulo. Diarsipkan dari versi asli tanggal 3 August 2020. Diakses tanggal 3 August 2020.

cnn.com

CNN, Stephanie Halasz, Kara Fox and Amy Cassidy. "AstraZeneca's Oxford coronavirus vaccine is 70% effective on average, data shows, with no safety concerns". CNN. Diakses tanggal 2021-03-25.

cnnindonesia.com

"Vaksin Oxford-AstraZeneca Diuji Klinis pada Anak". CNN Indonesia. Diakses tanggal 2021-03-25.

covid19vaccinetrial.co.uk

"COVID-19 Vaccine Trials | COVID-19". covid19vaccinetrial.co.uk. Diakses tanggal 2020-04-11.
"COVID-19 Vaccine Trials | COVID-19". covid19vaccinetrial.co.uk. Diakses tanggal 2021-03-25.

detik.com

health.detik.com

Pramudiarja, AN Uyung. "Efektifkah Vaksin Oxford-AstraZeneca pada Varian Corona Afsel? Ini Jawabannya". detikcom. Diakses tanggal 2021-03-25.

doi.org

O'Reilly P (26 May 2020). "A Phase III study to investigate a vaccine against COVID-19". ISRCTN (Registry). doi:10.1186/ISRCTN89951424 . ISRCTN89951424.
Cines, Douglas B.; Bussel, James B. (16 April 2021). "SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia". New England Journal of Medicine. 384 (23): 2254–2256. doi:10.1056/NEJMe2106315 . PMC 8063912  Periksa nilai |pmc= (bantuan). PMID 33861524 Periksa nilai |pmid= (bantuan).
Lai, Chih-Cheng; Ko, Wen-Chien; Chen, Chih-Jung; Chen, Po-Yen; Huang, Yhu-Chering; Lee, Ping-Ing; Hsueh, Po-Ren (8 July 2021). "COVID-19 vaccines and thrombosis with thrombocytopenia syndrome". Expert Review of Vaccines. Taylor and Francis Group. 20 (8): 1027–1035. doi:10.1080/14760584.2021.1949294. PMID 34176415 Periksa nilai |pmid= (bantuan). Diakses tanggal 4 October 2021.
Greinacher, Andreas; Thiele, Thomas; Warkentin, Theodore E.; Weisser, Karin; Kyrle, Paul A.; Eichinger, Sabine (9 April 2021). "Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination". New England Journal of Medicine. 384 (22): 2092–2101. doi:10.1056/NEJMoa2104840 . PMC 8095372  Periksa nilai |pmc= (bantuan). PMID 33835769 Periksa nilai |pmid= (bantuan).
Smadja, David; Yue, Qun-Ying; Chocron, Richard; Sanchez, Olivier; Lillo-Le Louet, Agnes (1 July 2021). "Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase". European Respiratory Journal. 58 (1). doi:10.1183/13993003.00956-2021 . ISSN 1399-3003. PMC 8051185  Periksa nilai |pmc= (bantuan). PMID 33863748 Periksa nilai |pmid= (bantuan).
Mallapaty, Smriti; Callaway, Ewen (2021-03-24). "What scientists do and don't know about the Oxford–AstraZeneca COVID vaccine". Nature (dalam bahasa Inggris). doi:10.1038/d41586-021-00785-7.
Wise, Jacqui (2021-02-03). "Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval". BMJ (dalam bahasa Inggris). 372: n326. doi:10.1136/bmj.n326. ISSN 1756-1833. PMID 33536232 Periksa nilai |pmid= (bantuan).
Hung, Ivan F. N.; Poland, Gregory A. (2021-03-06). "Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster". The Lancet (dalam bahasa English). 397 (10277): 854. doi:10.1016/S0140-6736(21)00528-6. ISSN 0140-6736. PMID 33676614 Periksa nilai |pmid= (bantuan).

europa.eu

ema.europa.eu

"Vaxzevria: EMA advises against use in people with history of capillary leak syndrome". European Medicines Agency (Siaran pers). 11 June 2021. Diarsipkan dari versi asli tanggal 11 June 2021. Diakses tanggal 11 June 2021.
"Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR". European Medicines Agency (EMA). Diarsipkan dari versi asli tanggal 21 April 2021. Diakses tanggal 27 March 2021. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"COVID-19 vaccine safety update Vaxzevria" (PDF). European Medicines Agency (EMA). 29 March 2021. Diarsipkan dari versi asli (PDF) tanggal 13 April 2021. Diakses tanggal 12 April 2021.
"COVID-19 vaccine safety update Vaxzevria" (PDF). European Medicines Agency (EMA). 11 May 2021. Diarsipkan dari versi asli (PDF) tanggal 26 July 2021. Diakses tanggal 15 May 2021.
"Vaxzevria: COVID-19 vaccine safety update" (PDF). European Medicines Agency (EMA). 14 July 2021. Diarsipkan dari versi asli (PDF) tanggal 20 July 2021. Diakses tanggal 23 July 2021.

fiercepharma.com

"Oxford Biomedica snags manufacturing equipment to ramp up production of COVID-19 vaccine". FiercePharma (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

gavi.org

"The COVID-19 vaccine race". www.gavi.org (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

gov.uk

"Information for UK recipients on COVID 19 Vaccine AstraZeneca". GOV.UK (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

hindustantimes.com

"Oxford vaccine against Covid-19 in final stage of clinical trials". Hindustan Times (dalam bahasa Inggris). 2020-06-24. Diakses tanggal 2021-03-25.

indianexpress.com

"Explained: What latest efficacy data of Oxford-AstraZeneca Covid-19 vaccine means". The Indian Express (dalam bahasa Inggris). 2021-03-24. Diakses tanggal 2021-03-25.

indiatimes.com

economictimes.indiatimes.com

"Five things to know about the AstraZeneca/Oxford vaccine". The Economic Times. Diakses tanggal 2021-03-25.

lstmed.ac.uk

"COVID-19 Oxford Vaccine Trial". LSTM (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

msf.org

"Governments must demand all coronavirus COVID-19 vaccine deals are made public | MSF". Médecins Sans Frontières (MSF) International (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

nationalgeographic.com

"Oxford vaccine enters final phase of COVID-19 trials. Here's what happens now". Science (dalam bahasa Inggris). 2020-07-27. Diakses tanggal 2021-03-25.

nature.com

Mallapaty, Smriti; Callaway, Ewen (2021-03-24). "What scientists do and don't know about the Oxford–AstraZeneca COVID vaccine". Nature (dalam bahasa Inggris). doi:10.1038/d41586-021-00785-7.

nih.gov

ncbi.nlm.nih.gov

Cines, Douglas B.; Bussel, James B. (16 April 2021). "SARS-CoV-2 Vaccine–Induced Immune Thrombotic Thrombocytopenia". New England Journal of Medicine. 384 (23): 2254–2256. doi:10.1056/NEJMe2106315 . PMC 8063912  Periksa nilai |pmc= (bantuan). PMID 33861524 Periksa nilai |pmid= (bantuan).
Lai, Chih-Cheng; Ko, Wen-Chien; Chen, Chih-Jung; Chen, Po-Yen; Huang, Yhu-Chering; Lee, Ping-Ing; Hsueh, Po-Ren (8 July 2021). "COVID-19 vaccines and thrombosis with thrombocytopenia syndrome". Expert Review of Vaccines. Taylor and Francis Group. 20 (8): 1027–1035. doi:10.1080/14760584.2021.1949294. PMID 34176415 Periksa nilai |pmid= (bantuan). Diakses tanggal 4 October 2021.
Greinacher, Andreas; Thiele, Thomas; Warkentin, Theodore E.; Weisser, Karin; Kyrle, Paul A.; Eichinger, Sabine (9 April 2021). "Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination". New England Journal of Medicine. 384 (22): 2092–2101. doi:10.1056/NEJMoa2104840 . PMC 8095372  Periksa nilai |pmc= (bantuan). PMID 33835769 Periksa nilai |pmid= (bantuan).
Smadja, David; Yue, Qun-Ying; Chocron, Richard; Sanchez, Olivier; Lillo-Le Louet, Agnes (1 July 2021). "Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase". European Respiratory Journal. 58 (1). doi:10.1183/13993003.00956-2021 . ISSN 1399-3003. PMC 8051185  Periksa nilai |pmc= (bantuan). PMID 33863748 Periksa nilai |pmid= (bantuan).
Wise, Jacqui (2021-02-03). "Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval". BMJ (dalam bahasa Inggris). 372: n326. doi:10.1136/bmj.n326. ISSN 1756-1833. PMID 33536232 Periksa nilai |pmid= (bantuan).
Hung, Ivan F. N.; Poland, Gregory A. (2021-03-06). "Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster". The Lancet (dalam bahasa English). 397 (10277): 854. doi:10.1016/S0140-6736(21)00528-6. ISSN 0140-6736. PMID 33676614 Periksa nilai |pmid= (bantuan).

ouh.nhs.uk

"Vaccine information - COVID-19 Staff FAQs - Oxford University Hospitals". www.ouh.nhs.uk. Diakses tanggal 2021-03-25.

ourworldindata.org

"Coronavirus (COVID-19) Vaccinations - Statistics and Research". Our World in Data. Diakses tanggal 2021-03-25.

ox.ac.uk

"Oxford team to begin novel coronavirus vaccine research". University of Oxford (dalam bahasa Inggris). 2020-02-07. Diakses tanggal 2020-11-28.

research.ox.ac.uk

"USA, Chile and Peru interim trial data show Oxford-AstraZeneca vaccine is safe and highly effective". www.research.ox.ac.uk (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

pharmaceutical-technology.com

"UK rollout of AZ/Oxford Covid-19 vaccine: what you need to know". www.pharmaceutical-technology.com. Diakses tanggal 2021-03-25.

politico.eu

"Oxford/AstraZeneca vaccine batch suspended in Austria after death". POLITICO (dalam bahasa Inggris). 2021-03-07. Diakses tanggal 2021-03-25.

practio.co.uk

"Coronavirus vaccine side effects: what to know". practio.co.uk (dalam bahasa Inggris). Diarsipkan dari versi asli tanggal 2021-04-19. Diakses tanggal 2021-03-25.

reuters.com

Staff, Reuters (2021-03-23). "Factbox: How AstraZeneca-Oxford developed Britain's home-grown COVID-19 vaccine". Reuters (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

sciencefocus.com

"Oxford coronavirus vaccine 'significantly reduces viral load' in monkeys". BBC Science Focus Magazine (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

sciencemag.org

CohenFeb. 8, Jon; 2021; Pm, 2:15 (2021-02-08). "South Africa suspends use of AstraZeneca's COVID-19 vaccine after it fails to clearly stop virus variant". Science | AAAS (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

sky.com

news.sky.com

"COVID-19: AstraZeneca denies 'stockpile' claims, saying 29m vaccine doses found in factory are for EU and developing nations". Sky News (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

tandfonline.com

Lai, Chih-Cheng; Ko, Wen-Chien; Chen, Chih-Jung; Chen, Po-Yen; Huang, Yhu-Chering; Lee, Ping-Ing; Hsueh, Po-Ren (8 July 2021). "COVID-19 vaccines and thrombosis with thrombocytopenia syndrome". Expert Review of Vaccines. Taylor and Francis Group. 20 (8): 1027–1035. doi:10.1080/14760584.2021.1949294. PMID 34176415 Periksa nilai |pmid= (bantuan). Diakses tanggal 4 October 2021.

telegraph.co.uk

Kelly-Linden, Jordan (2021-03-25). "Oxford-AstraZeneca Q&A: How effective is the Covid-19 vaccine, and how is it different to Pfizer?". The Telegraph (dalam bahasa Inggris). ISSN 0307-1235. Diakses tanggal 2021-03-25.

thelancet.com

Hung, Ivan F. N.; Poland, Gregory A. (2021-03-06). "Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster". The Lancet (dalam bahasa English). 397 (10277): 854. doi:10.1016/S0140-6736(21)00528-6. ISSN 0140-6736. PMID 33676614 Periksa nilai |pmid= (bantuan).

ukri.org

"The Oxford vaccine". www.ukri.org (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

usatoday.com

Weintraub, Karen. "COVID-19 vaccine from AstraZeneca-Oxford slightly less effective than first touted: 76% rather than 79% against disease, updated data shows". USA TODAY (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

verywellhealth.com

Zimlich, Rachael (March 22, 2021). "An Overview of the AstraZeneca-Oxford COVID-19 Vaccine". verywellhealth. Diakses tanggal 25 Maret 2021.

voaindonesia.com

"Vaksin Oxford-AstraZeneca Hadapi Kemunduran Baru". VOA Indonesia. Diakses tanggal 2021-03-25.

web.archive.org

Walsh, Nick; Shelley, Jo; Duwe, Eduardo; Bonnett, William (27 July 2020). "The world's hopes for a coronavirus vaccine may run in these health care workers' veins". CNN. São Paulo. Diarsipkan dari versi asli tanggal 3 August 2020. Diakses tanggal 3 August 2020.
"Investigating a Vaccine Against COVID-19". ClinicalTrials.gov (Registry). United States National Library of Medicine. 26 May 2020. NCT04400838. Diarsipkan dari versi asli tanggal 11 October 2020. Diakses tanggal 14 July 2020.
"A Phase 2/3 study to determine the efficacy, safety and immunogenicity of the candidate Coronavirus Disease (COVID-19) vaccine ChAdOx1 nCoV-19". EU Clinical Trials Register (Registry). European Union. 21 April 2020. EudraCT 2020-001228-32. Diarsipkan dari versi asli tanggal 5 October 2020. Diakses tanggal 3 August 2020.
"Vaxzevria: EMA advises against use in people with history of capillary leak syndrome". European Medicines Agency (Siaran pers). 11 June 2021. Diarsipkan dari versi asli tanggal 11 June 2021. Diakses tanggal 11 June 2021.
"Vaxzevria (previously COVID-19 Vaccine AstraZeneca) EPAR". European Medicines Agency (EMA). Diarsipkan dari versi asli tanggal 21 April 2021. Diakses tanggal 27 March 2021. Text was copied from this source which is © European Medicines Agency. Reproduction is authorized provided the source is acknowledged.
"COVID-19 vaccine safety update Vaxzevria" (PDF). European Medicines Agency (EMA). 29 March 2021. Diarsipkan dari versi asli (PDF) tanggal 13 April 2021. Diakses tanggal 12 April 2021.
"COVID-19 vaccine safety update Vaxzevria" (PDF). European Medicines Agency (EMA). 11 May 2021. Diarsipkan dari versi asli (PDF) tanggal 26 July 2021. Diakses tanggal 15 May 2021.
"Vaxzevria: COVID-19 vaccine safety update" (PDF). European Medicines Agency (EMA). 14 July 2021. Diarsipkan dari versi asli (PDF) tanggal 20 July 2021. Diakses tanggal 23 July 2021.
"Coronavirus vaccine side effects: what to know". practio.co.uk (dalam bahasa Inggris). Diarsipkan dari versi asli tanggal 2021-04-19. Diakses tanggal 2021-03-25.

who.int

"The Oxford/AstraZeneca COVID-19 vaccine: what you need to know". www.who.int (dalam bahasa Inggris). Diakses tanggal 2021-03-25.
"AstraZeneca ChAdOx1-S/nCoV-19 [recombinant], COVID-19 vaccine". www.who.int (dalam bahasa Inggris). Diakses tanggal 2021-03-25.

worldcat.org

Smadja, David; Yue, Qun-Ying; Chocron, Richard; Sanchez, Olivier; Lillo-Le Louet, Agnes (1 July 2021). "Vaccination against COVID-19: insight from arterial and venous thrombosis occurrence using data from VigiBase". European Respiratory Journal. 58 (1). doi:10.1183/13993003.00956-2021 . ISSN 1399-3003. PMC 8051185  Periksa nilai |pmc= (bantuan). PMID 33863748 Periksa nilai |pmid= (bantuan).
Wise, Jacqui (2021-02-03). "Covid-19: New data on Oxford AstraZeneca vaccine backs 12 week dosing interval". BMJ (dalam bahasa Inggris). 372: n326. doi:10.1136/bmj.n326. ISSN 1756-1833. PMID 33536232 Periksa nilai |pmid= (bantuan).
Hung, Ivan F. N.; Poland, Gregory A. (2021-03-06). "Single-dose Oxford–AstraZeneca COVID-19 vaccine followed by a 12-week booster". The Lancet (dalam bahasa English). 397 (10277): 854. doi:10.1016/S0140-6736(21)00528-6. ISSN 0140-6736. PMID 33676614 Periksa nilai |pmid= (bantuan).
Kelly-Linden, Jordan (2021-03-25). "Oxford-AstraZeneca Q&A: How effective is the Covid-19 vaccine, and how is it different to Pfizer?". The Telegraph (dalam bahasa Inggris). ISSN 0307-1235. Diakses tanggal 2021-03-25.